Wedgewood Communications

NJ 07733, new-jersey · Marketing agency

Visit website

Wedgewood Communications operates today under the brand "Wedgewood Health," a full-service specialty healthcare communications and marketing agency headquartered in Holmdel, New Jersey. The agency focuses exclusively on pharmaceutical and life-sciences brands, blending "scientific expertise, cutting-edge technology, and creativity" through a proprietary four-stage "DEEP" process (Discovery, Engagement, Elevation, Preservation). Its published portfolio names four real, trademarked pharmaceutical brand campaigns — SKYTROFA (pediatric growth hormone deficiency), OFEV (idiopathic pulmonary fibrosis / interstitial lung disease), LUPKYNIS (lupus nephritis), and AZSTARYS (ADHD) — giving it a genuinely differentiated, verifiable niche compared to generalist marketing shops. Leadership includes named executives with decades of healthcare-communications and creative experience, and one leader's creative work has been recognized by several named industry publications and awards bodies.

Our take

Wedgewood Communications (now branded Wedgewood Health) is a Holmdel, NJ-based specialty healthcare communications agency serving pharmaceutical and life-sciences brands exclusively. Its published work includes named campaigns for real prescription drug brands (SKYTROFA, OFEV, LUPKYNIS, AZSTARYS), and its named leadership team includes an executive with individual creative-industry recognition. It lacks published quantified results and pricing.

Strengths

Risk factors

Best fit for

Who should look elsewhere

Hiring advice

Ask for quantified outcomes (e.g., awareness lift, prescription trends, media performance) tied to the named SKYTROFA, OFEV, LUPKYNIS, or AZSTARYS campaigns, since none are published. Confirm current team headcount and account-team structure directly, and clarify regulatory/medical-legal review capabilities given the pharma vertical's compliance requirements.

How it compares

Unlike generalist marketing agencies that claim broad multi-industry experience, Wedgewood Communications differentiates itself through an exclusive healthcare/pharmaceutical focus, a named methodology ("DEEP"), and real, named campaign work for FDA-regulated prescription brands. This makes it a stronger, more verifiable choice than generalist competitors specifically for pharma/life-sciences marketing needs, though buyers should still request quantified performance data directly since none is published.

Conclusion

Wedgewood Communications (Wedgewood Health) is a genuine, well-differentiated specialty healthcare marketing agency with named leadership, real named pharmaceutical brand case work, and individual creative-industry recognition. It is a credible choice for pharma/life-sciences marketing specifically, though prospective clients should request quantified results and current pricing directly, since neither is published on the site.

Frequently Asked Questions

What does Wedgewood Communications specialize in?

It exclusively serves pharmaceutical and life-sciences brands, providing healthcare communications, market-shaping strategy, and creative campaign work.

What real client work has the agency published?

Named case studies for four real prescription drug brands: SKYTROFA, OFEV, LUPKYNIS, and AZSTARYS.

Who leads the agency?

President Danielle Cranwell (25+ years in healthcare communications) and EVP of Creative and Digital Services Keith Testa (20+ years in creative, individually recognized by several industry bodies).

Where is the agency located?

Holmdel, New Jersey — the address and phone number are published directly on its site.

Does the agency publish pricing or quantified campaign results?

No. Neither pricing nor performance metrics for its named case studies are published on the site.